The cancer diagnostics company is hours away from losing funding for its tests through the US Medicare system.
Net profit of $1.5b in the year ended September, with margins under pressure and higher costs.
The NZX-listed medicinal cannabis company wants to raise $3.1m under a pro-rata renounceable rights offer.
Unitholders were also told at today's AGM there's no plan to bring management of the trust in-house.
Fashion trends and regulations are moving in favour of ethically sourced wool, and Australasian producers could benefit.
Westpac CEO Catherine McGrath refuted the suggestion that the big banks were engaged in a cosy pillow fight.
Board chair Anna Stove assures shareholders it is ‘no longer at proof of concept’.
Australian PE firm calls off special shareholder meeting, sees ‘constructive path forward’.
A number of key metrics beat the same period last year but were well down on the six months to end-March.
Blair Turnbull to step down after five years with the insurance company.